These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11604353)

  • 1. [Cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood stem-cell products].
    Douay L
    Bull Cancer; 2001 Sep; 88(9):826-32. PubMed ID: 11604353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methods of mobilizing hematopoietic cells, their collection using cell separation, purging--processing of pathologic cells and enrichment with CD 34+ cells--negative and positive selection].
    Walter Z; Szostek M; Mensah P; Lorenz F; Weglarska D; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():22-7. PubMed ID: 10494178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purging of peripheral blood progenitor cell autografts and treatment of minimal residual disease.
    Brugger W; Scheding S; Bock T; Ziegler B; Kanz L
    Stem Cells; 1997; 15 Suppl 1():159-65. PubMed ID: 9368336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of hematopoietic cells and their clinical use.
    Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
    Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo manipulation of hematopoietic stem and progenitor cells.
    Kanz L; Brugger W; Scheding S
    Stem Cells; 1998; 16 Suppl 1():199-204. PubMed ID: 11012163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of cell therapy.
    Yee GC
    Pharmacotherapy; 1996; 16(3 Pt 2):109S-115S. PubMed ID: 8726590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow support and bone disease in metastatic breast cancer.
    Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
    Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High dose therapy with transplantation of autologous peripheral hematopoietic stem cells. I. Basic principles and clinical development].
    Gunsilius E; Petzer A; Gastl G
    Acta Med Austriaca; 1997; 24(3):97-101. PubMed ID: 9312975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R; Klingebiel T; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
    Silvestri F; Baccarani M
    Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients.
    Bruserud O; Tjønnfjord G; Gjertsen BT; Foss B; Ernst P
    Stem Cells; 2000; 18(5):343-51. PubMed ID: 11007918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity.
    Li N; Feugier P; Serrurrier B; Latger-Cannard V; Lesesve JF; Stoltz JF; Eljaafari A
    Exp Hematol; 2007 Mar; 35(3):507-15. PubMed ID: 17309831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.